Study record · SLU-PP-332
In-vitro human liver metabolism study for SLU-PP-332
Human-derived liver metabolism work identified metabolites relevant to detection, but did not administer the compound to people.
Key result
Human-derived liver metabolism work identified metabolites relevant to detection, but did not administer the compound to people.
Study details
Study designIn-vitro human-derived metabolism / anti-doping study
PopulationHuman liver S9 fraction
RouteIn vitro
Regimen / exposureSLU-PP-332 incubation with human liver S9
DurationLaboratory metabolism study
ComparatorAnalytical controls
Primary endpoint / questionMetabolite identification
Safety resultNo clinical safety information generated.
Key limitationsHuman-derived tissue is not human clinical exposure.
Registry / identifierPMID 41688415